Hsct - Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Hsct? On this page you'll find 281 study documents about Hsct.
Page 4 out of 281 results
Sort by
-
BMTCN PRACTICE TEST B WITH 100% CORRECT ANSWERS
- Exam (elaborations) • 42 pages • 2023
-
Available in package deal
-
- $14.99
- + learn more
Patients who have received an HSCT should receive which of the following annual immunizations? 
A. Yellow Fever 
B. Intranasal influenza 
C. Inactive influenza 
D. Live rotavirus 
C. Inactive influenza is recommended yearly. 
 
 
 
What is an advantage of using umbilical cord blood for an HSCT? 
A. The cells exhibit an earlier time to engraftment. 
B. An unlimited supply of stem cells is available. 
C. The graft-versus-tumor effect is avoided. 
D. An HLA match with the recipient is not required....
-
BMTCN Review 2023-Amy updated to pass
- Exam (elaborations) • 42 pages • 2023
- Available in package deal
-
- $21.99
- + learn more
BMTCN Review 2023-Amy 
Which of the following is an example of a myeloid cell? 
 
A. Thymus-derived cells (T cells) 
B. Bone marrow-derived cells (B cells) 
C. Monocytes 
D. Natural killer cells - correct answer C. Monocytes 
 
Several factors affect immune reconstitution following hematopoietic stem cell transplantation. These include all of the following EXCEPT: 
 
A. Recipients's response to conditioning regimen 
B. Viral infections 
C. Chronic GVHD 
D. Longevity of mature lymphocytes presen...
-
BMTCN Test B Question and answers correctly solved 2023/2024
- Exam (elaborations) • 18 pages • 2023
-
Available in package deal
-
- $13.99
- + learn more
BMTCN Test B Question and answers correctly solved 2023/2024Transplant-related toxicity is a barrier that contributes to the underutilization for which of the following diseases? 
 
A. Non-Hodgkin lymphoma 
B. Acute myeloid leukemia 
C. Sickle cell disease 
D. Neuroblastoma - correct answer C. Sickle cell disease 
 
Despite success of HSCT in sickle cell disease, barriers to successful HSCT include lack of a suitable donor, transplant related toxicity and immunologic graft rejection. 
 
Which ...
-
BMTCN TEST QUESTIONS WITH CORRECT ANSWERS
- Exam (elaborations) • 61 pages • 2024
-
Available in package deal
-
- $7.99
- + learn more
A patient developed type 4 PTLD three years after an allogeneic HSCT. Which of the 
following treatment interventions would the nurse expect an order for? - 
ANSWER-Aggressive chemotherapy 
Red bone marrow produces - ANSWER-hematopoietic stems cells that create red blood 
cells, white blood cells and platelets and is found in the long and flat bones 
yellow bone marrow and fat cells produce - ANSWER-stromal stem cells that produce 
fat, cartilage and bone and are found in the long bones. 
hemato...
-
CIC Studying 2023: CIC Practice Exam Questions and answers
- Exam (elaborations) • 22 pages • 2024
-
- $7.99
- + learn more
CIC Studying 2023: CIC Practice Exam 
Questions and answers 
Recipients of allogenic hematopoeietic stem transplantation (HSCT) should be placed in rooms 
with how many air exchanges per hour? 
3 
5 
10 
12 - answer-12. A greater number of air exchanges per hour prevent opportunistic infections 
among stem cell transplant recipients 
Because of the increased risk of infection with parenteral nutrition, the maximum infusion time 
for a parenteral lipid bag to run is? 
6 hours 
12 hours 
18 hours ...
Too much month left at the end of the money?
-
BMTCN Practice Questions & Answers with rationales
- Exam (elaborations) • 128 pages • 2024
- Available in package deal
-
- $7.99
- + learn more
The administration of Epstein-Barr virus (EBV) cytotoxic T-lymphocytes has been found 
to be a feasible therapeutic option in which EBV mediated-disease process? 
a) Lymphoproliferative disease 
b) Neuroblastoma 
c) Nasopharyngeal rhabdomyosarcoma 
d) Acute lymphocytic leukemia 
A) Lymphoproliferative disease 
Post-Transplant Lymphoproliferative Disorder PTLD is an aggressive, rare, and 
potentially fatal proliferation of lymphoid cells of donor origin, usually occurring within 
the first four m...
-
BMTCN Practice Test B question n answers graded A+
- Exam (elaborations) • 13 pages • 2023
- Available in package deal
-
- $17.99
- + learn more
BMTCN Practice Test B 
Patients who have received an HSCT should receive which of the following annual immunizations? 
A. Yellow Fever 
B. Intranasal influenza 
C. Inactive influenza 
D. Live rotavirus - correct answer C. Inactive influenza is recommended yearly. 
 
What is an advantage of using umbilical cord blood for an HSCT? 
A. The cells exhibit an earlier time to engraftment. 
B. An unlimited supply of stem cells is available. 
C. The graft-versus-tumor effect is avoided. 
D. An HLA mat...
-
BMTCN TEST QUESTIONS WITH CORRECT ANSWERS
- Exam (elaborations) • 61 pages • 2024
-
Available in package deal
-
- $7.99
- + learn more
A patient developed type 4 PTLD three years after an allogeneic HSCT. Which of the 
following treatment interventions would the nurse expect an order for? - 
ANSWER-Aggressive chemotherapy 
Red bone marrow produces - ANSWER-hematopoietic stems cells that create red blood 
cells, white blood cells and platelets and is found in the long and flat bones 
yellow bone marrow and fat cells produce - ANSWER-stromal stem cells that produce 
fat, cartilage and bone and are found in the long bones. 
hemato...
-
CIC Studying 2023: CIC Practice Exam Questions
- Exam (elaborations) • 22 pages • 2024
-
Available in package deal
-
- $12.99
- + learn more
Recipients of allogenic hematopoeietic stem transplantation (HSCT) should be placed in rooms with how many air exchanges per hour? 
 
3 
5 
10 
12 - Answer-12. A greater number of air exchanges per hour prevent opportunistic infections among stem cell transplant recipients 
 
Because of the increased risk of infection with parenteral nutrition, the maximum infusion time for a parenteral lipid bag to run is? 
 
6 hours 
12 hours 
18 hours 
24 hours - Answer-Maximum 12 hours. Lipid emulsions pose ...
-
BMTCN Practice Questions and answers 2024
- Exam (elaborations) • 128 pages • 2024
-
Available in package deal
-
- $7.99
- + learn more
The administration of Epstein-Barr virus (EBV) cytotoxic T-lymphocytes has been found 
to be a feasible therapeutic option in which EBV mediated-disease process? 
a) Lymphoproliferative disease 
b) Neuroblastoma 
c) Nasopharyngeal rhabdomyosarcoma 
d) Acute lymphocytic leukemia 
A) Lymphoproliferative disease 
Post-Transplant Lymphoproliferative Disorder PTLD is an aggressive, rare, and 
potentially fatal proliferation of lymphoid cells of donor origin, usually occurring within 
the first four m...
$6.50 for your textbook summary multiplied by 100 fellow students... Do the math: that's a lot of money! Don't be a thief of your own wallet and start uploading yours now. Discover all about earning on Stuvia